Wave Life Sciences (WVE) Reports Q4 Loss, Tops Revenue Estimates

Wave Life Sciences (WVE) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -8.26%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.3 per share when it actually produced a loss of $0.32, delivering a surprise of -6.67%.Over the last four quarters, th ...